Observation of prescribing behavioral change based on pharmacogenetic (PGt) results
Not Applicable
Recruiting
- Conditions
- We will target the patients who are receiving treatment in Fujita Health University Hospital.
- Registration Number
- JPRN-jRCT1040220156
- Lead Sponsor
- Iwata Nakao
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
1 Patients who have obtained informed consent or assent according to their capacity to understand before participation in the study.
2 Patients at least 18 years of age at the time of consent.
3 Patients who are seen in any clinical department at Fujita Health University Hospital at present.
Exclusion Criteria
Not in particular
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We evaluate the attending doctors'prescription changes for drug selections or dosages related to the risk genetic variants based on the Report related to the efficacy of a medicine and anticipation of a side effect of medication.The endpoint is any changes in prescription in 6 months.
- Secondary Outcome Measures
Name Time Method We evaluate the attending doctors'prescription changes in every months for drug selections or dosages related to the risk genetic variants based on the Report related to the efficacy of a medicine and anticipation of a side effect of medication. <br>The points set at 1,2,3,4 and 5 months after the enrollment and evaluate the trend for the timing of the prescription changes.